PMC:7228307 / 5454-5746 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"59","span":{"begin":33,"end":40},"obj":"Gene"},{"id":"63","span":{"begin":67,"end":79},"obj":"Species"}],"attributes":[{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Gene:2213"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":287,"end":291},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T18","span":{"begin":87,"end":90},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T64","span":{"begin":13,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T65","span":{"begin":16,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0008882"},{"id":"T66","span":{"begin":33,"end":35},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T67","span":{"begin":159,"end":160},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T68","span":{"begin":228,"end":229},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T69","span":{"begin":264,"end":265},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T70","span":{"begin":266,"end":272},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T71","span":{"begin":287,"end":291},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T29","span":{"begin":287,"end":291},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"59","span":{"begin":33,"end":40},"obj":"Gene"},{"id":"63","span":{"begin":67,"end":79},"obj":"Species"}],"attributes":[{"id":"A59","pred":"pubann:denotes","subj":"59","obj":"Gene:2213"},{"id":"A63","pred":"pubann:denotes","subj":"63","obj":"Tax:9606"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T29","span":{"begin":0,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T34","span":{"begin":287,"end":291},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}

{"project":"LitCovid-sentences","denotations":[{"id":"T29","span":{"begin":0,"end":292},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell."}